小细胞前列腺癌患者的急性感觉运动性副肿瘤神经病。
Acute sensorimotor paraneoplastic neuropathy in a patient with small cell prostate cancer.
机构信息
Oncology, Beatson West of Scotland Cancer Centre, Glasgow, Glasgow, UK
Neurology, Institute of Neurological Sciences, Glasgow, UK.
出版信息
BMJ Case Rep. 2024 Feb 27;17(2):e258380. doi: 10.1136/bcr-2023-258380.
Abstract
The authors describe a patient with a background of metastatic small cell prostate cancer who presented with a rapidly evolving sensorimotor neuropathy with bulbar features closely resembling Guillain-Barré syndrome, with a good initial response to intravenous immunoglobulins and platinum-based chemotherapy. This represented a likely paraneoplastic manifestation of the patient's urological malignancy.
摘要
作者描述了一名转移性小细胞前列腺癌患者，其表现为迅速进展的感觉运动神经病，具有类似于吉兰-巴雷综合征的球部特征，静脉注射免疫球蛋白和铂类化疗有良好的初始反应。这可能是患者泌尿系统恶性肿瘤的副肿瘤表现。
相似文献
1
Acute sensorimotor paraneoplastic neuropathy in a patient with small cell prostate cancer.
BMJ Case Rep. 2024 Feb 27;17(2):e258380. doi: 10.1136/bcr-2023-258380.
2
[Anti-Hu antibody-positive paraneoplastic limbic encephalitis with acute motor sensory neuropathy resembling Guillain-Barré syndrome: a case study].
Rinsho Shinkeigaku. 2015;55(12):921-5. doi: 10.5692/clinicalneurol.cn-000772. Epub 2015 Oct 28.
3
Small cell prostate cancer with anti-Hu positive peripheral neuropathy.
J Urol. 2002 Jul;168(1):192.
4
Paraneoplastic sensorimotor polyneuropathy in prostatic adenocarcinoma: A case report.
Medicine (Baltimore). 2018 Apr;97(15):e0030. doi: 10.1097/MD.0000000000010030.
5
A Case Report of Pediatric Paraneoplastic Dysautonomia.
Pediatr Emerg Care. 2020 Dec;36(12):e742-e744. doi: 10.1097/PEC.0000000000001558.
6
Paraneoplastic subacute sensory neuronopathy in association with adenocarcinoma of the prostate.
BMJ Case Rep. 2011 Jul 28;2011:bcr0420114077. doi: 10.1136/bcr.04.2011.4077.
7
A case of IVIg responsive paraneoplastic SOX1 peripheral neuropathy in a male with breast carcinoma.
J Neuroimmunol. 2021 Mar 15;352:577492. doi: 10.1016/j.jneuroim.2021.577492. Epub 2021 Jan 21.
8
Paraneoplastic neuropathy: wide-ranging clinicopathological manifestations.
Curr Opin Neurol. 2011 Oct;24(5):504-10. doi: 10.1097/WCO.0b013e32834a87b7.
9
Intravenous immunoglobulin in therapy of peripheral neuropathy.
Clin Rev Allergy Immunol. 2005 Dec;29(3):271-9. doi: 10.1385/CRIAI:29:3:271.
10
Subacute Sensorimotor Neuropathy Accompanied by Anti-ganglioside GM1 Antibody in a Patient with Lung Cancer.
Intern Med. 2018 Nov 15;57(22):3289-3292. doi: 10.2169/internalmedicine.0667-17. Epub 2018 Jul 6.
本文引用的文献
1
Cancer Diagnosis and Prognosis After Guillain-Barré Syndrome: A Population-Based Cohort Study.
Clin Epidemiol. 2022 Jul 19;14:871-878. doi: 10.2147/CLEP.S369908. eCollection 2022.
2
Paraneoplastic neurological syndromes: a practical approach to diagnosis and management.
Pract Neurol. 2022 Feb;22(1):19-31. doi: 10.1136/practneurol-2021-003073. Epub 2021 Sep 11.
3
Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes.
Neurol Neuroimmunol Neuroinflamm. 2021 May 18;8(4). doi: 10.1212/NXI.0000000000001014. Print 2021 Jul.
4
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
5
Clinical features of neuroendocrine prostate cancer.
Eur J Cancer. 2019 Nov;121:7-18. doi: 10.1016/j.ejca.2019.08.011. Epub 2019 Sep 13.
6
Genomic correlates of clinical outcome in advanced prostate cancer.
Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11428-11436. doi: 10.1073/pnas.1902651116. Epub 2019 May 6.
7
A Case of Paraneoplastic Guillain-Barré Syndrome Associated with Squamous Cell Carcinoma of the Lung.
Cureus. 2018 Aug 24;10(8):e3202. doi: 10.7759/cureus.3202.
8
Neurological paraneoplastic syndromes: an update.
Curr Opin Oncol. 2018 Nov;30(6):359-367. doi: 10.1097/CCO.0000000000000479.
9
Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies.
J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):789-792. doi: 10.1136/jnnp-2017-316904. Epub 2017 Oct 30.
10
Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling.
Cancer Cell. 2017 Oct 9;32(4):474-489.e6. doi: 10.1016/j.ccell.2017.09.003.
Zotero 插件